Pharmaceutical Supply – Ibuprofen Tablets, USP

The contract pertains to the supply of FDA-compliant Ibuprofen Tablets, USP in 100-tablet bottles to military medical facilities under the Department of Defense, with full adherence to United States Pharmacopeia standards and specific labeling requirements mandated by the DoD. All products must meet stringent quality and regulatory criteria to ensure safety, efficacy, and consistency for use in military healthcare settings. The packaging and labeling must strictly follow DoD specifications, including chain-of-custody tracking, barcoding, and dosage accuracy to align with military medical protocols. The solicitation is classified as a subcontract under NAICS code 325412 for pharmaceutical manufacturing and is directed to suppliers capable of delivering consistent, government-qualified pharmaceuticals. The response deadline is set for July 20, 2026, with the contract performance location identified as Fort Lewis, Washington, ZIP 98433-9500. The award will be managed through the Medical Supply Chain Pharm FSA, part of the broader DoD supply infrastructure, ensuring timely distribution to frontline medical units. Suppliers must demonstrate capacity for large-scale production, compliance with federal pharmaceutical regulations, and the ability to meet military delivery timelines without disruption.